Encompass Health Future Growth
Future criteria checks 2/6
Encompass Health is forecast to grow earnings and revenue by 9.6% and 8.7% per annum respectively. EPS is expected to grow by 6.8% per annum. Return on equity is forecast to be 21.3% in 3 years.
Key information
9.6%
Earnings growth rate
6.8%
EPS growth rate
| Healthcare earnings growth | 20.8% |
| Revenue growth rate | 8.7% |
| Future return on equity | 21.3% |
| Analyst coverage | Good |
| Last updated | 15 Nov 2024 |
Recent future growth updates
Encompass Health Corporation Just Beat EPS By 20%: Here's What Analysts Think Will Happen Next
Apr 26
Recent updates
Encompass Health Corporation's (NYSE:EHC) Price Is Out Of Tune With Earnings
Oct 21Is Encompass Health (NYSE:EHC) Using Too Much Debt?
Oct 03Encompass Health's (NYSE:EHC) Shareholders Will Receive A Bigger Dividend Than Last Year
Aug 27Encompass Health (NYSE:EHC) Will Pay A Larger Dividend Than Last Year At $0.17
Aug 10These 4 Measures Indicate That Encompass Health (NYSE:EHC) Is Using Debt Reasonably Well
Jun 27Do Encompass Health's (NYSE:EHC) Earnings Warrant Your Attention?
Jun 09Encompass Health Corporation's (NYSE:EHC) Business Is Yet to Catch Up With Its Share Price
May 23Encompass Health Corporation Just Beat EPS By 20%: Here's What Analysts Think Will Happen Next
Apr 26Is Encompass Health Corporation (NYSE:EHC) Expensive For A Reason? A Look At Its Intrinsic Value
Apr 11Encompass Health's (NYSE:EHC) Dividend Will Be $0.15
Mar 09What Is Encompass Health Corporation's (NYSE:EHC) Share Price Doing?
Feb 25Do Encompass Health's (NYSE:EHC) Earnings Warrant Your Attention?
Feb 07We Think Encompass Health (NYSE:EHC) Can Stay On Top Of Its Debt
Jan 09Encompass Health (NYSE:EHC) Has Announced A Dividend Of $0.15
Dec 13Encompass Health (NYSE:EHC) Is Due To Pay A Dividend Of $0.15
Nov 28Is There Now An Opportunity In Encompass Health Corporation (NYSE:EHC)?
Nov 21Are Encompass Health Corporation (NYSE:EHC) Investors Paying Above The Intrinsic Value?
Nov 08Is Encompass Health (NYSE:EHC) A Risky Investment?
Oct 10Do Encompass Health's (NYSE:EHC) Earnings Warrant Your Attention?
Sep 07Encompass Health Corporation: Solid Quarterly Report Makes For A Buy
Aug 14What Does Encompass Health Corporation's (NYSE:EHC) Share Price Indicate?
Aug 10Encompass Health: Incremental CapEx Adds Tremendous Torque To Flywheel
Aug 07Encompass Health (NYSE:EHC) Is Paying Out A Dividend Of $0.15
Jul 23Does Encompass Health (NYSE:EHC) Have A Healthy Balance Sheet?
May 22Is Now The Time To Look At Buying Encompass Health Corporation (NYSE:EHC)?
May 01Encompass Health declares $0.15 dividend
Feb 23Encompass Health: Incremental Returns On Capital Key, Confirm Buy
Feb 17Encompass Health 2023 adjusted earnings per share estimate range below consensus
Feb 07Is Now An Opportune Moment To Examine Encompass Health Corporation (NYSE:EHC)?
Jan 23Encompass Health Non-GAAP EPS of $0.67 beats by $0.03, revenue of $1.09B beats by $30M
Oct 26Encompass Health declares $0.15 dividend
Oct 19Should You Investigate Encompass Health Corporation (NYSE:EHC) At US$48.81?
Oct 18Encompass health to build a rehabilitation hospital in the Villages, Florida
Sep 26Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 6,330 | 534 | 195 | N/A | 8 |
| 12/31/2025 | 5,825 | 485 | 312 | 901 | 12 |
| 12/31/2024 | 5,348 | 440 | 348 | 903 | 12 |
| 9/30/2024 | 5,215 | 432 | 270 | 925 | N/A |
| 6/30/2024 | 5,071 | 409 | 215 | 872 | N/A |
| 3/31/2024 | 4,957 | 387 | 239 | 862 | N/A |
| 12/31/2023 | 4,801 | 362 | 268 | 851 | N/A |
| 9/30/2023 | 4,692 | 357 | 241 | 822 | N/A |
| 6/30/2023 | 4,574 | 336 | 97 | 677 | N/A |
| 3/31/2023 | 4,450 | 280 | 144 | 715 | N/A |
| 12/31/2022 | 4,349 | 256 | 122 | 706 | N/A |
| 9/30/2022 | 4,254 | 232 | 81 | 657 | N/A |
| 6/30/2022 | 4,175 | 242 | 216 | 765 | N/A |
| 3/31/2022 | 3,844 | 253 | 216 | 776 | N/A |
| 12/31/2021 | 4,015 | 298 | 170 | 716 | N/A |
| 9/30/2021 | 4,187 | 316 | 381 | 872 | N/A |
| 6/30/2021 | 4,350 | 318 | 408 | 868 | N/A |
| 3/31/2021 | 4,693 | 304 | 410 | 834 | N/A |
| 12/31/2020 | 3,566 | 193 | 300 | 705 | N/A |
| 9/30/2020 | 4,614 | 265 | 244 | 641 | N/A |
| 6/30/2020 | 4,602 | 285 | 169 | 582 | N/A |
| 3/31/2020 | 4,663 | 342 | 89 | 505 | N/A |
| 12/31/2019 | 4,605 | 358 | 231 | 635 | N/A |
| 9/30/2019 | 4,517 | 317 | 238 | 598 | N/A |
| 6/30/2019 | 4,423 | 308 | 362 | 682 | N/A |
| 3/31/2019 | 4,355 | 309 | 417 | 706 | N/A |
| 12/31/2018 | 4,277 | 290 | 486 | 762 | N/A |
| 9/30/2018 | 4,190 | 339 | 476 | 735 | N/A |
| 6/30/2018 | 4,104 | 316 | N/A | 712 | N/A |
| 3/31/2018 | 4,003 | 288 | N/A | 694 | N/A |
| 12/31/2017 | 3,914 | 271 | N/A | 658 | N/A |
| 9/30/2017 | 3,841 | 260 | N/A | 642 | N/A |
| 6/30/2017 | 3,771 | 256 | N/A | 645 | N/A |
| 3/31/2017 | 3,710 | 256 | N/A | 646 | N/A |
| 12/31/2016 | 3,643 | 247 | N/A | 640 | N/A |
| 9/30/2016 | 3,576 | 228 | N/A | 616 | N/A |
| 6/30/2016 | 3,432 | 217 | N/A | 602 | N/A |
| 3/31/2016 | 3,280 | 198 | N/A | 552 | N/A |
| 12/31/2015 | 3,116 | 181 | N/A | 502 | N/A |
| 9/30/2015 | 2,857 | 173 | N/A | 438 | N/A |
| 6/30/2015 | 2,678 | 172 | N/A | 415 | N/A |
| 3/31/2015 | 2,520 | 204 | N/A | 440 | N/A |
| 12/31/2014 | 2,374 | 208 | N/A | 445 | N/A |
| 9/30/2014 | 2,336 | 144 | N/A | 476 | N/A |
| 6/30/2014 | 2,303 | 148 | N/A | 479 | N/A |
| 3/31/2014 | 2,266 | 228 | N/A | 456 | N/A |
| 12/31/2013 | 2,247 | 229 | N/A | 470 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: EHC's forecast earnings growth (9.6% per year) is above the savings rate (2.6%).
Earnings vs Market: EHC's earnings (9.6% per year) are forecast to grow slower than the US market (15.3% per year).
High Growth Earnings: EHC's earnings are forecast to grow, but not significantly.
Revenue vs Market: EHC's revenue (8.7% per year) is forecast to grow slower than the US market (8.9% per year).
High Growth Revenue: EHC's revenue (8.7% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: EHC's Return on Equity is forecast to be high in 3 years time (21.3%)